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Psychosis Risk Candidate ZNF804A Localizes to
Synapses and Regulates Neurite Formation and
Dendritic Spine Structure
P.J. Michael Deans, Pooja Raval, Katherine J. Sellers, Nicholas J.F. Gatford, Sanjay Halai,
Rodrigo R.R. Duarte, Carole Shum, Katherine Warre-Cornish, Victoria E. Kaplun,
Graham Cocks, Matthew Hill, Nicholas J. Bray, Jack Price, and Deepak P. Srivastava
ABSTRACT
BACKGROUND: Variation in the gene encoding zinc ﬁnger binding protein 804A (ZNF804A) is associated with
schizophrenia and bipolar disorder. Evidence suggests that ZNF804A is a regulator of gene transcription and is
present in nuclear and extranuclear compartments. However, a detailed examination of ZNF804A distribution and its
neuronal functions has yet to be performed.
METHODS: The localization of ZNF804A protein was examined in neurons derived from human neural progenitor
cells, human induced pluripotent stem cells, or in primary rat cortical neurons. In addition, small interfering RNA-
mediated knockdown of ZNF804A was conducted to determine its role in neurite formation, maintenance of dendritic
spine morphology, and responses to activity-dependent stimulations.
RESULTS: Endogenous ZNF804A protein localized to somatodendritic compartments and colocalized with the
putative synaptic markers in young neurons derived from human neural progenitor cells and human induced
pluripotent stem cells. In mature rat neurons, Zfp804A, the homolog of ZNF804A, was present in a subset of dendritic
spines and colocalized with synaptic proteins in speciﬁc nanodomains, as determined by super-resolution
microscopy. Interestingly, knockdown of ZNF804A attenuated neurite outgrowth in young neurons, an effect
potentially mediated by reduced neuroligin-4 expression. Furthermore, knockdown of ZNF804A in mature neurons
resulted in the loss of dendritic spine density and impaired responses to activity-dependent stimulation.
CONCLUSIONS: These data reveal a novel subcellular distribution for ZNF804A within somatodendritic compart-
ments and a nanoscopic organization at excitatory synapses. Moreover, our results suggest that ZNF804A plays an
active role in neurite formation, maintenance of dendritic spines, and activity-dependent structural plasticity.
Keywords: Autism spectrum disorder, Bipolar disorder, Dendritic spine, GluN1, Human neurons, Induced pluripotent
stem cells (iPSCs), Neural progenitor cells, PSD-95, Psychosis, Schizophrenia, Super-resolution microscopy,
Synapse
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The single nucleotide polymorphism rs1344706 within the
second intron of ZNF804A was the ﬁrst to show genome-
wide signiﬁcant association for the broad psychosis pheno-
type (1). Subsequent studies have conﬁrmed association
between common variants in ZNF804A and both schizo-
phrenia (SCZ) and bipolar disorder (BP) (2,3). In addition, copy
number variations and chromosomal abnormalities affecting
the ZNF804A gene have also been identiﬁed in cases of SCZ,
BP, anxiety disorders, and autism spectrum disorders (ASDs)
(4–7). Whereas the rs1344706 single nucleotide polymorphism
has been associated with brain function and structure (8,9),
relatively little is known about the cellular functions of zinc
ﬁnger binding protein 804A (ZNF804A).
In silico modeling has revealed that ZNF804A encodes a
protein containing a C2H2-type zinc-ﬁnger domain (10), a motif
best known for binding DNA and regulating transcription (11).
Several splice variants of ZNF804A have also been identiﬁed
(10), including ZNF804AE3/E4, which has been reported to
show reduced expression in patients with SCZ (12), and a
transcript containing an alternative exon, termed exon 2.2 (13)
(Supplemental Figure S1A).
Two independent studies have shown that the risk allele of
rs1344706 is associated with reduced expression of ZNF804A
RNA in the human fetal brain (12,14). Knockdown of ZNF804A
in human neural progenitor cells (hNPCs) or in developing
neurons derived from human induced pluripotent stem cells
(hiPSC-neurons) results in altered expression of genes
involved in cell adhesion, neurite outgrowth, and synapse
formation, as well as cytokine signaling (15,16). Similarly,
overexpression of ZNF804A in rat neural progenitor cells
(NPCs) has been reported to alter the expression of several
genes associated with SCZ (17). This latter study further
Crown Copyright & 2016 Published by Elsevier Inc on behalf of Society of Biological Psychiatry.
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localized the rat homologue of ZNF804A, Zfp804A, to the
nucleus of rat NPCs (17). More recently, ZNF804A/Zfp804A
has also been found along neurites of developing rat neurons
(18) and in extranuclear compartments in adult human
neurons (12). However, a detailed characterization of ZNF804A/
Zfp804A subcellular distribution has not been performed to
date. Critically, the role of this protein in regulating neuronal
morphology and function has yet to be determined.
In this study, we demonstrate that ZNF804A localizes to
nuclear and extranuclear compartments in hNPCs and is
found at putative synapses in neurons differentiated from
hNPCs or hiPSCs. With the use of a small interfering RNA
(siRNA)-based approach, we ﬁnd that loss of ZNF804A
attenuates the development of early neuronal morphology.
Moreover, we show that ZNF804A knockdown results in
reduced expression of the adhesion protein neuroligin-4
(NLGN4) and that overexpression of NLGN4 rescues aberrant
neurite outgrowth in ZNF804A knockdown neurons. In mature
neurons, super-resolution microscopy reveals that Zfp804A is
located at the base of spines and at perisynaptic domains
within the spine head. Here, Zfp804A is present in distinct
nanodomains that contain the synaptic protein postsynaptic
density (PSD)-95 and N-methyl-D-aspartate (NMDA) receptor
subunits. Finally, knockdown of Zfp804A in mature cortical
neurons causes a loss of dendritic spine density and impairs
activity-dependent structural plasticity. These data reveal a
novel subcellular distribution for ZNF804A/Zfp8084A as well
as determining a functional role in the formation of early
neuronal morphology and the regulation of excitatory
synapses.
METHODS AND MATERIALS
See the Supplement for further detailed Methods and Materials.
CTX0E16 hNPCs and Neurons
Experiments using hNPCs were carried out using the
CTX0E16 neural cell line obtained from ReNeuron Ltd. (www.
reneuron.com) under a Material Transfer Agreement. This
karyotypically normal hNPC line was derived from 12-week
fetal cortical neuroepithelium and conditionally immortalized
using a c-mycERTAM transgene (19,20). Proliferation and
neuralization of CTX0E16 cells were carried out as previously
described (19). Brieﬂy, neuralization was achieved by replacing
Dulbecco’s Modiﬁed Eagle Medium with Ham’s F-12 with
Neurobasal Medium supplemented with B27 supplement (Life
Technologies, Paisley, United Kingdom).
Structured Illumination Microscopy
Structured illumination microscopy (SIM) imaging was carried
out on primary rat cortical neurons transfected with green
ﬂuorescent protein (GFP) and coimmunostained for ZNF804A
(GeneTex, Irvine, CA) and either PSD-95 or NMDA receptor
subunit 1 (GluN1). Images were acquired with a Nikon (King-
ston, United Kingdom) N-SIM super-resolution microscope.
Acquisition was performed in a 3D SIM mode using the 1003
1.49 NA total internal reﬂection ﬂuorescence objective lens
with 13 to 25 z steps per stack at a step interval of 0.12 mm.
Image reconstructions were performed with Nikon N-SIM
software. Final images, including z projections and brightness
and contrast adjustments, were carried out in ImageJ (National
Institutes of Health, Bethesda) and MetaMorph (Molecular
Devices, Sunnyvale, CA).
RESULTS
Subcellular Distribution of ZNF804A in hNPCs and
Neurons
We ﬁrst examined the subcellular distribution of ZNF804A in a
conditionally immortalized human neural cell line, CTX0E16
(19). Polymerase chain reaction analysis of oligo(dT)-primed
complementary DNA showed expression of ZNF804A
exon 4 [included in ZNF804A variant b (10) and E2E3 (12)
as well as full-length ZNF804A transcripts] in proliferating
CTX0E16 cells and during their early neuronal differentiation
(Supplemental Figure S1B). Expression of exon 2.2 (13) and
E2E3 (12) was also detected in these cells at the assayed
time points using transcript-speciﬁc primers (Supplemental
Figure S1B). However, quantitative polymerase chain reaction
analysis revealed that transcripts probed by ZNF804Aexon4
primers were far more abundant than ZNF804AE3/E4 alone
in both proliferative and differentiated CTX0E16 cells
(Supplemental Figure S1C). Interestingly, ZNF804Aexon4 levels
were signiﬁcantly reduced as CTX0E16 NPCs differentiated
into neurons, whereas ZNF804AE3/E4 expression was unal-
tered (Supplemental Figure S1C). To examine the distribution
of ZNF804A we used an antibody raised against the C-
terminal region (C2C3; GeneTex). This antibody detected a
major protein band at 135 kDa corresponding to full-length
ZNF804A in days differentiated (DD) 35 CTX0E16-neuronal
lysates (see Supplemental Figures S1–S5 and Supplemental
Results for additional information). Importantly, two previously
characterized siRNAs targeting ZNF804A (15) speciﬁcally
reduced this major protein band (Figure 1A), indicating that
this antibody is speciﬁc for full-length ZNF804A; both siRNAs
also reduced ZNF804Aexon4 messenger RNA expression
(Supplemental Figure S1H).
With the use of the C2C3 antibody, we examined the
cellular distribution of ZNF804A in CTX0E16 hNPC prolifer-
ative and differentiated (DD28) neurons. ZNF804A was present
in the nuclei of hNPCs and DD28 neurons (Figure 1B) but was
also observed in the soma and processes of hNPCs and along
microtubule-associated protein 2 (MAP2)-positive dendrites in
DD28 neurons (Figure 1B). A similar distribution was also seen
in DD10 and DD15 CTX0E16 neurons (Supplemental Figure
S4A). In CTX0E16 NPCs and hEK293 cells, exogenously
expressed GFP-ZNF804A also localized to the nucleus, soma,
and at the plasma membrane (Supplemental Figure S4B).
Exogenously expressed myc-ZNF804A in early stage
CTX0E16 neurons also localized along double cortin-positive
neurites further supporting an extranuclear distribution in
neurons (Supplemental Figure S4C). Furthermore, expression
of a Halo-tagged ZNF804A construct in SH-SY5Y cells also
displayed an extranuclear distribution in both live and ﬁxed
cells (Supplemental Figure S5A, B). Interestingly, ZNF804A
staining was more abundant in the nucleus compared with the
soma in CTX0E16 NPCs. Conversely, in CTX0E16 neurons
ZNF804A immunoreactivity was greater in the soma than in
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the nucleus (Figure 1C), indicating that the distribution of the
protein changed over time with the development of a neuronal
morphology. Collectively, these data indicate that ZNF804A is
predominately present in the nucleus of hNPCs but is more
abundant in extranuclear locations in neurons.
ZNF804A Is Present Along Dendrites and Colocalizes
With Synaptic Proteins
Examination of DD28 CTX0E16 neurons revealed ZNF804A
immunoreactive staining as punctate structures in the nucleus,
in the cell soma, and along MAP2-positive dendrites
(Figure 1D, E). In distal MAP2-postive dendrites, a subpopu-
lation of ZNF804A puncta (44%) colocalized with the pro-
totypical synaptic marker, PSD-95 (Figure 1E, F). Moreover,
40% of ZNF804A puncta colocalized with the NMDA
receptor subunit, GluN1 (Figure 1E, F). In DD35 CTX0E16
neurons expressing enhanced GFP, ZNF804A puncta were
observed along dendrites as well as within ﬁlopodia-like
dendritic protrusions, further suggesting that the protein is
targeted to postsynaptic compartments (Figure 1G). These
data suggest that ZNF804A is targeted to dendrites and,
furthermore, partially localizes to putative synapses in devel-
oping neurons.
ZNF804A Regulates Early Neurite Formation
Because previous studies have suggested that ZNF804A
regulates the expression of genes involved in cell adhesion,
neurite outgrowth, and synaptic transmission (15,19), we
reasoned that ZNF804A might inﬂuence the development of
early neuronal morphology. With the use of siRNAs, we
reduced ZNF804A expression in CTX0E16 neurons and exam-
ined neurite outgrowth after 7 days of differentiation. ZNF804A
protein levels were reduced by between 30% and 40%
by siRNA 1 and siRNA 2, respectively (Figure 1A and
Supplemental Figures S1H and 3A–C). Measurements of
neuronal morphology revealed that total neurite length was
signiﬁcantly reduced in the presence of ZNF804A knockdown
(total neurite length: scramble siRNA, 36.1 6 1.9 mm; siRNA 1,
27.8 6 0.5 mm; siRNA 2, 24.6 6 1.3 mm; Figure 2A, B).
ZNF804A has been suggested to control the expression of
NLGN4X (16), a member of the neuroligin-neurexin family of
adhesion proteins. This protein is associated with ASDs, and it
localizes to and regulates synapse density (21,22). Intriguingly,
we observed a signiﬁcant reduction in NLGN4 levels in cell
lysates from ZNF804A siRNA CTX0E16 neurons; the adhesion
protein N-cadherin and GluA2–alpha-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid (AMPA) receptor subunit
were unaffected (Figure 2C). NLGN4 has been suggested to
be involved in neurite outgrowth (23); however, this has not
been validated. Nevertheless, we reasoned that if NLGN4 was
important for neurite outgrowth, exogenous expression of this
protein would rescue deﬁcits in neurite length in siRNA-treated
cells. Consistent with this, total neurite length in siRNA 1- or
2-treated cells, overexpressing HA-NLGN4, was signiﬁcantly
increased compared with siRNA-alone conditions but did not
differ from control conditions (Figure 2E, F). Collectively, these
data demonstrate that ZNF804A plays a role in early neurito-
genesis in human neurons, an effect that may be mediated via
the control of NLGN4 expression.
ZNF804A Localizes to Synapses and Regulates
Neuritogenesis in hiPSC Neurons
HiPSCs provide a novel cellular system in which to conﬁrm
and elucidate the impact of genetic variations on cellular
phenotypes (24–26). We were therefore interested in determin-
ing whether the distribution of ZNF804A and its purported role
in neuritogenesis could be recapitulated in hiPSC neurons.
HiPSCs were differentiated using a protocol that robustly
generates forebrain excitatory neurons (Supplemental Figure
S6A–E) (27,28). In day (D) 35 hiPSC neurons ZNF804A was
detected in the nucleus, in the soma, and along the dendrites
of MAP2-positive hiPSC neurons (Figure 3A). ZNF804A was
also observed as punctate structures along distal portions of
MAP2-positive dendrites (Figure 3B). As with CTX0E16 neu-
rons, a subset of ZNF804A puncta (39%) colocalized with
PSD-95 (Figure 3B, C) and approximately 45% colocalized
with GluN1 (Figure 3B, C).
To conﬁrm a role for ZNF804A in neuritogenesis, we
knocked down ZNF804A using siRNAs in hiPSC neurons
derived from three individuals (M1, M2, and M3); cells were
transfected on D23 and ﬁxed 7 days later (D30). Knockdown of
ZNF804A was conﬁrmed by immunocytochemical analysis:
siRNA 1 and siRNA 2 reduced ZNF804A protein levels by
between 30% and 40% (Figure 3D, E). Assessment of neurite
outgrowth across all three lines revealed a signiﬁcant reduc-
tion in total neurite length in hiPSC neurons transfected with
either siRNA 1 or siRNA 2 (normalized neurite length: blank,
0.91 6 0.09 mm; scramble siRNA, 1 6 0.07 mm; siRNA 1,
Figure 1. Extranuclear distribution of zinc ﬁnger binding protein 804A (ZNF804A) in CTX0E16 cells. (A) Western blot of ZNF804A and quantiﬁcation of
knockdown after 7-day small interfering RNA (siRNA) treatment in early stage CTX0E16 cells using C2C3 anti-ZNF804A antibody. Expression of the major
protein band at 135 kDa (indicated by red arrow) is signiﬁcantly reduced in the presence of siRNA 1 and 2 (n 5 3 independent experiments); asterisks
indicate nonspeciﬁc bands. (B) Distribution of endogenous ZNF804A in proliferative (DD0) and differentiated (DD28) CTX0E16 cells as determined by
immunocytochemical analysis using C2C3 antibody. ZNF804A immunoreactive puncta were observed within the nucleus (white arrowheads), soma, and in
neurite-like protrusions (yellow arrows). (C) Quantiﬁcation of relative staining intensity of ZNF804A in nuclei and cytoplasm of DD0 and DD28 CTX0E16 cells
(n 5 3 independent experiments). (D) In DD28 CTX0E16 neurons ZNF804A was localized to the nucleus (white arrowheads) and along microtubule-associated
protein 2 (MAP2)-positive dendrites (yellow arrows) using the GeneTex anti-ZNF804A antibody. Orthogonal projections conﬁrm ZNF804A presence at nuclear
and extranuclear sites. (E) ZNF804A is present along distal dendrites of DD28 CTX0E16 neurons, where a subset of puncta colocalize with putative synaptic
markers. White arrowheads indicate colocalization of ZNF804A with postsynaptic density (PSD)-95 or the N-methyl-D-aspartate (NMDA) receptor subunit 1
(GluN1). (F) Quantiﬁcation of ZNF804A, PSD-95, GluN1, and colocalized puncta density in DD28 CTX0E16 neurons (puncta per 10 mm: ZNF804A, 2.8 6 0.38;
PSD-95, 3.4 6 0.32; GluN1, 3.1 6 0.4; ZNF804A 1 PSD-95, 1.5 6 0.14; ZNF804A 1 GluN1, 1.2 6 0.17; n 5 17 neurons from three independent experiments).
(G) ZNF804A puncta were present within the heads of dendritic spines of DD35 CTX0E16 neurons transfected with enhanced green ﬂuorescent protein
(eGFP). Yellow arrows indicate ZNF804A puncta within the heads of dendritic spines, white arrowheads indicate puncta within the dendritic shaft. Scale bars
5 20 mm (B), 5 mm (D, E, G). Ab, antibody; a.u., arbitrary unit; DAPI, 40,6-diamidino-2-phenylindole. **p , .05 (A), **p , .01 (C).
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Figure 2. Small interfering RNA (siRNA)-mediated knockdown of zinc ﬁnger binding protein 804A (ZNF804A) in CTX0E16 neurons. (A) Representative images
of ZNF804A staining and neurite length in early stage (DD7) CTX0E16 neurons after a 7-day treatment with no transfection (blank), control (scramble), or
ZNF804A-targeting siRNAs. (B) Total neurite length was signiﬁcantly reduced in neurons treated with both siRNAs relative to the scramble siRNA control
(n 5 3 independent experiments). (C, D) Western blot analysis of synaptic and adhesion protein expression in control and siRNA expressing CTX0E16 neurons.
In ZNF804A knockdown cells, neuroligin-4 (NLGN4) is signiﬁcantly reduced; N-cadherin and AMPA receptor subunit 2 (GluA2) are unaffected. (E) Representative
images of early stage (DD7) CTX0E16 neurons after a 7-day treatment with no transfection (blank), control (scramble), or ZNF804A-targeting siRNAs, with or
without exogenous expression of HA-NLGN4 for 2 days. (F) Quantiﬁcation of neurite outgrowth of cells in panel E. siRNA-treated cells had signiﬁcantly reduced
outgrowth compared with blank or scramble conditions. Neurons treated with ZNF804A-siRNA and HA-NLGN4 had signiﬁcantly longer neurites than siRNA
alone conditions, but they did not differ from control conditions (n 5 3–4 independent experiments). Scale bars5 10 mm (A1), 50 mm (A2), and 20 mm (E). AMPA,
alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; a.u., arbitrary unit; DAPI, 40,6-diamidino-2-phenylindole; N-cad, N-cadherin. *p , .05, **p , .01.
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0.82 6 0.04 mm; siRNA 2, 0.83.6 6 0.08 mm; Figure 3D–G).
Taken together, these data demonstrate an extranuclear
distribution for ZNF804A in young human neurons and,
furthermore, indicate that at early stages of neuronal develop-
ment a subpopulation of the protein is present at putative
synapses in human neurons. Moreover, these data further
support a critical role for ZNF804A in neuritogenesis in young
human neurons.
Zfp804A Localizes to Synapses in Neurons With a
Mature Morphology
Because ZNF804A has been shown to be present in adult
human pyramidal neurons (12,29), and because our data
suggest that ZNF804A is present at putative synapses in
young neurons, we postulated that this protein may also be
present at synaptic sites in mature neurons. Thus, we exam-
ined the distribution of Zfp804A in primary rat cortical neurons.
Zfp804A was found to localize to nuclear and somatodendritic
compartments of cortical neurons (Figure 4A and
Supplemental Figure S7A). Along distal dendrites, Zfp804A
localized to dendritic shafts and in dendritic spines
(Supplemental Figure S7B, C): 44.5% 6 5.9% of spines were
positive for Zfp804A. Because spine morphology is thought to
be a critical indicator of synaptic function (30,31), we classiﬁed
dendritic spines that contained Zfp804A according to dendritic
spine area. Of spines that contained Zfp804A, the majority
(71.6%) of spines had an area less than 1.0 mm2 (Supplemental
Figure S7D). Interestingly, Zfp804A puncta were also observed
along axon-like processes, indicating a potential localization at
presynaptic sites (Supplemental Figure S8A). Consistent with
these immunostaining data, Western blot analysis of crude
synaptosomal preparations revealed a signiﬁcant enrichment
of Zfp804A in synaptic lysates (Figure 4B). Taken together,
these data indicate that Zfp804A is present within the dendritic
shaft and in presynaptic and postsynaptic structures in mature
neurons.
Subsynaptic Localization and Organization of
Zfp804A
There is now a growing appreciation that proteins within
dendritic spines are organized into subsynaptic domains
(32,33); the localization of these domains plays a critical role
in determining the precise functional role these proteins may
play (34–36). Therefore, we were interested in the subsynaptic
localization of Zfp804A within dendritic spines, because it may
provide additional insights into its role at synapses. Because
the resolution of traditional confocal microscopy is limited to
200 nm, we used SIM, a form of super-resolution micro-
scopy that exceeds this diffraction limit (37). With the use of
SIM we found that Zfp804A was located in nanoscopic
structures along dendrites and in spines (Supplemental
Figure S8B) and axon-like processes (Supplemental Figure S8C).
SIM imaging further revealed that Zfp804A was distributed into
small nanoscopic domains within spine heads (Figure 4C); line
scan analysis further conﬁrmed the enrichment of Zfp804A
within spine heads (Figure 4C, D). Zfp804A also localized to
distinct dendritic compartments and was present at the base
of dendritic spines (Figure 4C). Collectively, these data indi-
cate that Zfp804A is present at discrete nanoscopic compart-
ments in presynaptic and postsynaptic structures, and,
moreover, is distributed into small subsynaptic domains within
spines.
The organization of proteins within the PSD is critical for the
function of the synapse. Ultrastructural studies have shown
that both PSD-95 and GluN1 are core components of the PSD
(38). Given our data showing Zfp804A can be located in spine
heads (Figure 4C), we hypothesized that Zfp804A also coloc-
alize with synaptic proteins within spines. Confocal imaging
revealed that 52% of Zfp804A-positive spines contained
PSD-95 and that 43% contained GluN1 (Supplemental
Figure S8D, E). A subset of Zfp804A puncta also colocalize
with the presynaptic marker bassoon in mouse cortical
sections (Supplemental Figure S9A, B). SIM imaging revealed
a nonuniform distribution of Zfp804A within spine heads that
was surrounded by, and only partially colocalized with, PSD-
95. Intensity proﬁles across colocalized Zfp804A and PSD-95
in spines indicated a partial colocalization of the two proteins
(Figure 4E and Supplemental Figure S9C). Interestingly,
Zfp804A and GluN1 partially colocalized within spine heads;
this distribution was conﬁrmed by intensity proﬁles of colo-
calized puncta (Figure 4F and Supplemental Figure S9D).
Taken together, these data suggest that within spine heads
Zfp804A predominately displays a perisynaptic localization,
with a small amount of protein potentially present within
the PSD.
Zfp804A Is Required for the Maintenance of
Dendritic Spines and Activity-Dependent Structural
Plasticity
Our present data indicate that a subpopulation of Zfp804A
localizes to synapses, suggesting a potential role in the
maturation, or maintenance, of dendritic spines. Therefore,
we knocked down Zfp804a using siRNA 2, predicted to also
target Zfp804A; siRNA 2 reduced Zfp804A protein expression
Figure 3. Localization and small interfering RNA (siRNA)-mediated knockdown of zinc ﬁnger binding protein 804A (ZNF804A) in young human induced
pluripotent stem cell (hiPSC)-derived neurons. (A) In 35-day-old neurons differentiated from hiPSCs, ZNF804A puncta were observed in the nucleus (white
arrowheads) and along dendrites (yellow arrows) in XY, XZ, and YZ planes. (B) ZNF804A puncta are also found along distal microtubule-associated protein 2
(MAP2)-positive dendrites. Costaining with postsynaptic density (PSD)-95 or NMDA receptor subunit 1 (GluN1) reveals that a fraction of ZNF804A puncta
colocalize with either synaptic protein. (C) Quantiﬁcation of ZNF804A, PSD-95, GluN1, and colocalized puncta in hiPSC neurons (puncta per 10 mm:
ZNF804A, 2.5 6 0.36; PSD-95, 3.2 6 0.3; GluN1, 2.6 6 0.32; ZNF804A 1 PSD-95, 1.2 6 0.11; ZNF804A 1 GluN1, 1.0 6 0.15; n 5 16 neurons from three
independent experiments). (D) Representative images of ZNF804A staining and neurite length in early stage (day [D] 30) hiPSC-derived neurons after a 7-day
treatment with no transfection (blank), control (scramble), or ZNF804A-targeting siRNAs. (E) Quantiﬁcation of staining intensity seen in panel D. ZNF804A
expression was signiﬁcantly reduced in both siRNA treatment conditions relative to the scramble siRNA control (n 5 3 independent cell lines, carried out in
triplicate for each line). (F) Normalized total neurite length was signiﬁcantly reduced in neurons treated with both siRNAs relative to blank and scramble siRNA
control (n 5 3 independent cell lines, carried out in triplicate for each line). (G) Raw total neurite length data for siRNA-treated neurons from each hiPSC line.
Scale bars 5 5 mm (A, B), 10 mm (D1), and 50 mm (D2). a.u. arbitrary unit; DAPI, 40,6-diamidino-2-phenylindole; M1, subject 1; M2, subject 2; M3, subject 3.
*p , .05.
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by 35% (Figure 5A). A similar level of Zfp804A knockdown
was observed by immunocytochemical analysis (Figure 5B, C).
Neurons treated with siRNA 2 for 5 days had 35% fewer
spines than neurons expressing no siRNA or scramble siRNA
(Figure 5D). Interestingly, when we examined spine morphol-
ogy, no difference was seen in spine area, length, or breadth,
indicating that the reduction in linear density was due to a
loss of spines of no particular morphology (Figure 5E and
Supplemental Figure S10A–C). Because loss of ZNF804A in
young human neurons correlated with a reduced NLGN4
expression, a protein known to regulate synapse density
(21,22), we examined whether this molecule was also affected
by loss of Zfp804A expression. As predicted, NLGN4 was
reduced in Zfp804A knockdown neurons, whereas no changes
in the adhesion protein N-cadherin or the synaptic protein
synaptosomal-associated protein 25 expression were
observed (Figure 5G, H).
Because altering Zfp804A expression inﬂuenced spine
density, we reasoned that loss of Zfp804A may affect
activity-dependent spine plasticity. Therefore, we used a
well-characterized chemical long-term potentiation (cLTP)
protocol shown to cause a rapid increase in spine area and
density via activation of NMDA receptors (31,39). Application
of cLTP on control cells or neurons expressing scramble
siRNA resulted in a signiﬁcant increase in density (33%)
and spine area (24%) (Figure 5I, J). However, in Zfp804A
knockdown neurons, no increase in spine area was observed
after cLTP treatment, although spine density increased
(35%) to a level similar to unstimulated (basal) control levels
(Figure 5I, K). Collectively, these experiments demonstrate that
Zfp804a is required for spine maintenance and that loss of the
protein impairs the ability of neurons to respond fully to
activity-dependent simulations.
DISCUSSION
Variants in ZNF804A are associated with various neuropsychi-
atric conditions (1–6), and emerging evidence suggests that
synaptic pathology may be a key cellular substrate contribu-
ting to the pathophysiology of these disorders (30). Whereas
functional studies suggest that ZNF804A controls the expres-
sion of genes involved in cell adhesion, neurite outgrowth, and
synaptic transmission (15,19), little is known about the cellular
function of this susceptibility gene. Here, we present evidence
that ZNF804A/Zfp804a localizes to dendrites and synapses, in
both neurons derived from either hNPC or hiPSC sources and
mature rat cortical neurons. siRNA-mediated loss of ZNF804A
further reveals a role in establishing early neuronal morphol-
ogy, an effect potentially mediated by the ability of ZNF804A
to regulate the expression of the adhesion protein NLGN4, a
protein implicated in ASDs (21,22). In mature neurons, super-
resolution imaging revealed Zfp804A nanodomains at perisy-
naptic locations within dendritic spines, where it partially
colocalizes with synaptic proteins. Critically, siRNA-mediated
loss of Zfp804A resulted in a reduction in spine linear density
and impaired activity-dependent structural plasticity. Collec-
tively, these data suggest that ZNF804A/Zfp804A is involved
in early neurite outgrowth and also plays a role in regulating
spine maintenance and the ability of neurons to respond to
activity-dependent stimuli. Although some of these cellular
effects may be governed by the ability of ZNF804A/Zfp804A to
regulate NLGN4 expression, ZNF804A/Zfp804a may also play a
functional role at synapses and alter the expression of other
synaptic proteins. Importantly, because risk variants in ZNF804A
appear to alter its developmental expression (5,12,14), our data
provide an insight into how this could contribute to the patho-
physiology of psychotic and neurodevelopmental disorders.
ZNF804A has been posited as a putative transcription
factor owing to the presence of a C2H2 zinc-ﬁnger domain,
a motif that facilitates binding to speciﬁc DNA sequences
(10,11), and based on functional gene expression studies
(15,17,19). Consistent with this role, Zfp804a has been
reported to localize to the nucleus of rat progenitor cells
(17). However, in silico analysis of ZNF804A has suggested
that it may not act as a classical zinc-ﬁnger protein because
it only contains a single C2H2 motif, in contrast to other
members of the zinc-ﬁnger family that typically possess
multiple zinc-ﬁnger motifs (10). Our data indicate that
ZNF804A is highly present within the nucleus in undifferenti-
ated hNPCs and throughout the cell. In differentiated neurons,
a higher proportion of ZNF804A is found in the somatic
compartment. This pattern of distribution has also been
reported in developing rat neurons (18). Thus, ZNF804A
appears to be enriched within the nuclear compartment of
undifferentiated hNPCs, whereas in neurons it is distributed
along dendrites, axons, and synapses.
Interestingly, our data suggest that there is a change in the
cellular distribution of ZNF804A during neuralization, with
more protein located in the nucleus of hNPCs and in extra-
nuclear subcompartments in neurons. The change in distribu-
tion could be an indication of changes in isoform expression.
Quantitative polymerase chain reaction analysis indicates that
Figure 4. Zinc ﬁnger binding protein 804A (Zfp804A) is present at synapses in mature primary cortical neurons. (A) Representative confocal image,
including orthogonal views in the XZ and YZ planes, of a 25-day in vitro (DIV25) rat primary cortical neuron transfected with enhanced green ﬂuorescent
protein (GFP) and immunostained for endogenous Zfp804A (rodent homologue of ZNF804A). Expression of Zfp804A within the cell nucleus is indicated with
white arrowheads, and expression of Zfp804A within the cell soma and in proximal dendrites is indicated by yellow arrows. (B) Subcellular fractionation of
DIV25 rat primary cortical neurons. Note protein band around the predicted size of 137 kDa for Zfp804A within cell lysate, post-nuclear fraction (S1), and crude
synaptosomal fraction (P2), but not crude cytosolic fraction (S2), consistent with an enrichment of Zfp804A at synapses. (C) Super-resolution structured
illumination microscopy (SIM) images of Zfp804A subsynaptic localization in primary cortical neurons. Zfp804A is present in spine heads (white arrowheads)
and along the dendrite (red arrowheads). Outline of neuronal morphology is indicated by yellow dashed lines. Zfp804A signal could also be detected at the
base of spines (white arrowheads) and occasionally in spine necks (red open arrowheads). (D) Line scan analysis through the spine and shaft shows that
Zfp804A is enriched within the heads of spines. (E, F) High magniﬁcation SIM image of colocalized Zfp804A and (E) postsynaptic density (PSD)-95 or (F)
NMDA receptor subunit 1 (GluN1) puncta (indicated with red triangles) within GFP-transfected dendritic spines (outline of spine indicated with yellow dashed
lines); colocalization is indicated by white overlap. Intensity proﬁles of colocalized Zfp804A and either PSD-95 or GluN1 within spine heads demonstrates
partial colocalization of the puncta. Scale bars 5 5 mm (A), 1 mm (C), and 500 nm (E, F). a.u., arbitrary unit; DAPI, 40,6-diamidino-2-phenylindole; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase.
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although ZNF804AE3/E4 expression is not altered during early
neuralization, overall ZNF804Aexon4 transcripts were reduced.
The change in distribution could also reﬂect a change in the
function of the protein. Indeed, the presence of ZNF804A along
neurites/dendrites is consistent with our functional data reveal-
ing a role in establishing early neuronal morphology. However, it
is currently unclear whether the different ZNF804A isoforms
display different localizations or function differently. The recently
discovered disease-associated transcript ZNF804AE3/E4 (12)
lacks the C2H2-domain present in the full-length protein and
thus has no obvious ability to bind DNA or act as a transcription
factor. Therefore, to fully understand how this protein may
contribute to the pathophysiology of psychiatric disorders it is
critical to fully understand the distribution of all isoforms of
ZNF804A and, furthermore, the functional roles they play.
In developing human neurons, ZNF804A partially colocal-
ized with both PSD-95 and GluN1. Because these neurons
can form immature synaptic connections (19), it is possible
that ZNF804A is functionally present at putative synapses.
Interestingly, ZNF804A knockdown attenuated neuritogenesis;
concurrently, these cells display reduced expression of
NLGN4. NLGN4X expression has recently been shown to be
downregulated in ZNF804A knockdown hiPSCs (16), although
it is not clear whether this is due to ZNF804A directly
regulating NLGN4X expression. Although NLGN4 has been
implicated in neuritogenesis (23), no direct evidence has been
provided demonstrating a role in neurite formation. We show
that exogenous-overexpression of NGLN4 rescues aberrant
neurite outgrowth observed in ZNF804A knockdown neurons.
Whether this indicates that the effects of ZNF804A on neurite
outgrowth are dependent on the direct or indirect regulation of
NLGN4 expression will need to be established in future studies.
In mature neurons, Zfp804A was predominately located
along dendrites and within a subset of dendritic spines; it was
also detected in axon terminals. Super-resolution imaging
further revealed that Zfp804A could be found at the base of
and within the head of spines. Within spine heads, Zfp804A
appears to form nanodomains, which surround and integrate
within the PSD. PSD-95 and GluN1 partially surrounded
Zfp804A puncta, supporting an enrichment at perisynaptic
regions, and a potential participation in a larger protein
complex with synaptic proteins. The presence of ZNF804A
at the base of dendritic spines is also potentially interesting
when taken together with previous work showing that this
subsynaptic compartment is a key region where regulation of
messenger RNA occurs (40) and that C2H2 domains can
mediate protein-RNA interactions (11,41). We also ﬁnd that
loss of Zfp804A resulting in a reduction of dendritic spine
density also occurred concurrently with a reduction in NLGN4
expression, which has also been implicated in the regulation of
synapse density (21,22). However, it is not yet clear whether
Zfp804A also plays a functional role locally at synapses.
Interestingly, our data also indicate that Zfp804A knockdown
impairs rapid structural changes induced by cLTP, speciﬁcally
in the enlargement of spine size. Although this effect could be
driven by reduced expression of NLGN4 or other proteins,
note that Zfp804A preferentially localized to small spines. It is
these spines that readily undergo enlargement after cLTP (31);
therefore, it is possible that Zfp804A functions locally at
synapses in addition to regulating gene expression. Under-
standing whether Zfp804a contributes to local signaling at
synapses, in addition to regulation of gene transcription, is
crucial in further understanding the role of ZNF804A/Zfp804a
in physiological and pathological conditions. It should be
noted that although our data demonstrate a functional role
for ZNF804A/Zfp804A in controlling neuronal and synaptic
function based on siRNA-based approaches, interpretation of
the distribution of the protein should be noted with caution.
From our antibody characterization studies, the C2C3 anti-
body shows some level of nonspeciﬁcity by Western blot
(Supplemental Figures S1–S5), although overexpression and
knockdown studies indicate that C2C3 is speciﬁc for ZNF804A
in immunocytochemical analysis (Supplemental Figures S2–S5).
However, a true validation of antibody speciﬁcity can only be
demonstrated using tissue lacking all isoforms. Nevertheless,
our data examining the extracellular distribution are consistent
with previous reports (12,18) and critically with our overexpres-
sion/knockdown experiments and functional studies.
In conclusion, we ﬁnd ZNF804A/Zfp804A to be expressed
in discrete structures along the dendrites and at synapses and
to have a functional role in regulating neuronal and synaptic
morphology. Interestingly, the nanoscopic distribution of
ZNF804A/Zfp804A in spines indicates a potential functional
role in inﬂuencing local signaling at synapses. SCZ, BP, and
ASDs have all been shown to display overlapping cellular
deﬁcits, including reduced dendritic arborization and spine
Figure 5. Small interfering RNA (siRNA)-mediated knockdown of zinc ﬁnger binding protein 804A (Zfp804A) in rat primary cortical neurons.
(A) Representative Western blot of Zfp804A in 26-day in vitro (DIV26) primary rat cortical neurons after a 5-day treatment with no transfection (blank),
control (scramble), or ZNF804A-targeting siRNA. (B) Quantiﬁcation of the major protein band found at 135 kDa, roughly equal to the predicted molecular
mass of Zfp804A, revealed a signiﬁcant reduction in staining intensity compared with blank and control conditions (n 5 3 independent experiments).
(C) Representative confocal images of dendrites and dendritic spines after siRNA treatment of neurons as in panel A. (D) Quantiﬁcation of Zfp804A staining
intensity after 5-day siRNA treatment. Zfp804A was signiﬁcantly reduced in neurons treated with siRNA 2 in comparison with blank and control conditions (n
5 3 independent experiments and at least 12 cells per condition). (E) Quantiﬁcation of spine density after siRNA treatment (n 5 3 independent experiments
and at least 12 cells per condition). (F) Spine area was not found to be signiﬁcantly altered in neurons treated with siRNA 2 relative to the two control
conditions (n 5 3 independent experiments and at least 12 cells per condition). (G) Western blot analysis of cell lysates of blank, control, and siRNA-treated
neurons. (H) Quantiﬁcation of panel F reveals that neuroligin-4 (NLGN4), but not N-cadherin or synaptosomal-associated protein 25 (SNAP25), is signiﬁcantly
reduced in Zfp804A knockdown cells (n 5 3 independent experiments). (I) Representative confocal images of dendritic spines from neurons treated as in
panel A and after chemical long-term potentiation (cLTP) stimulation (n 5 3 independent experiments and 13–14 cells per condition). (J) Quantiﬁcation of
spine density in siRNA-treated cells after cLTP revealed that linear density was increased in all conditions; in Zfp804A cells, cLTP increased spine density
back to basal levels. (K) Quantiﬁcation of spine size (area) after cLTP revealed that loss of Zfp804A impaired the ability of cells to undergo structural plasticity
(n 5 3 independent experiments and 13–14 cells per condition). Scale bar 5 5 mm. Ab, antibody; a.u., arbitrary unit; GFP, green ﬂuorescent protein; N-Cad,
N-cadherin. *p , .05, **p , .01, ***p , .001.
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density (30). In addition, increasing evidence suggests that risk
factors implicated in these disorders converge onto a common
biological function: control of neuronal and synaptic structure
(30,42). It is therefore possible that dysregulation of ZNF804A
in these disorders could also contribute to altered neuronal
and synaptic structures seen in these disorders (30). Our study
further highlights how understanding the cellular function of
risk proteins may reveal novel functions, but it may also
identify how multiple psychiatric disorders may share genetic
risk factors and biological mechanisms.
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